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Abstract
Background: Smartphone manufacturers offer mobile health monitoring technology to their customers, including apps
using the built-in camera for heart rate assessment. This study aimed to test the diagnostic accuracy of such heart rate
measuring apps in clinical practice.
Methods: The feasibility and accuracy of measuring heart rate was tested on four commercially available apps using both
iPhone 4 and iPhone 5. ‘Instant Heart Rate’ (IHR) and ‘Heart Fitness’ (HF) work with contact photoplethysmography
(contact of fingertip to built-in camera), while ‘Whats My Heart Rate’ (WMH) and ‘Cardiio Version’ (CAR) work with
non-contact photoplethysmography. The measurements were compared to electrocardiogram and pulse oximetry-
derived heart rate.
Results: Heart rate measurement using app-based photoplethysmography was performed on 108 randomly selected
patients. The electrocardiogram-derived heart rate correlated well with pulse oximetry (r¼ 0.92), IHR (r¼ 0.83) and HF
(r¼ 0.96), but somewhat less with WMH (r¼ 0.62) and CAR (r¼ 0.60). The accuracy of app-measured heart rate as
compared to electrocardiogram, reported as mean absolute error (in bpm standard error) was 2 0.35 (pulse oxim-
etry), 4.5 1.1 (IHR), 2 0.5 (HF), 7.1 1.4 (WMH) and 8.1 1.4 (CAR).
Conclusions: We found substantial performance differences between the four studied heart rate measuring apps. The
two contact photoplethysmography-based apps had higher feasibility and better accuracy for heart rate measurement
than the two non-contact photoplethysmography-based apps.
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Introduction
Mobile electronic devices such as smartphones or tablets
are gaining increasing popularity worldwide. Recent
estimates suggest 7.7 billionmobile broadband subscrip-
tions in 2020, while the number of smartphone subscrip-
tions is expected to equal about 70% of the world’s
population.1 The ubiquitous use of smartphones
coupled with expanding mobile broadband connectivity
could change the way healthcare is accessed, monitored
and delivered (‘mobile health technologies’, mHealth).
mHealth is deﬁned by the practice of medicine sup-
ported by portable diagnostic devices.2 For healthcare
systems, the importance of mHealth strategies has been
demonstrated as they may play an important role in the
control of epidemic disease such as cholera3 or Ebola.4
On an individual patient level, mHealth technology can
be used, for example, to increase medication
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adherence5,6 or control of blood glucose levels and insu-
lin doses in patients with diabetes.7 For cardiac patients,
a wide array of smartphone-connected cardiac monitor-
ing devices and health apps for the diagnosis and pre-
vention of cardiovascular disease is available.8
Overall, it is estimated that the number of health-
related wearable sensors will reach 80 million in
2017.9 To reach the transformative potential of
mHealth, validation of the technical capabilities and
accuracy as well as the clinical impact of these technol-
ogies is needed.10 As heart rate monitoring is an essen-
tial component of almost all clinical situations, in the
present study we evaluated the usability and accuracy
of four diﬀerent heart rate measuring apps. The accur-
acy of the apps was compared to the electrocardiogram
(ECG) and pulse oximeter-derived heart rate using
medically approved professional devices.
Methods
Basic principles
Photoplethysmography (PPG) is based on the principle
that blood absorbs more light than the surrounding
tissue. In addition, variations in blood volume (i.e. in
systole and diastole) aﬀect the transmission or reﬂect-
ance of light.11 These two principles can be used to
detect blood ﬂow. The PPG technique is commercially
used in pulse oximeters for the determination of arterial
blood oxygen saturation (SaO2), achieved by comput-
ing the diﬀerences of light absorption in the red and
infrared range by oxygenated and deoxygenated
haemoglobin.12 In contrast, heart rate detection (but
not SaO2 measurement) based on PPG is feasible
using only light in the visible range.11
Two diﬀerent concepts of measuring heart rate by
PPG are known: contact and non-contact PPG. In
contact PPG, the subject places a ﬁnger on the built-
in camera of the phone. The camera is placed directly
on the skin and the built-in ﬂash provides the necessary
light source in the visible range for reﬂection by blood
cells (Figure 1(a)). In non-contact PPG, the camera is
used in the classic way by holding the camera in front of
the patient’s face (up to 1.5m away) without the need
for direct skin contact (Figure 1(b)). There is no need
for a dedicated light source, ambient light is suﬃcient.
Technology
Applications (apps). Overall, four commercially available
apps have been tested (downloaded from iTunes store).
For contact PPG, we used ‘Instant Heart Rate’ (IHR)
(version 3.0.1; Azumio Inc., USA) and ‘Heart Fitness’
(HF) (version 2.0.3; Senscare SAS, France). For non-
contact PPG, we tested ‘Whats My Heart Rate’
(WMH) (version 2.0; Vitrox Technologies, Malaysia)
and ‘Cardiio’ (CAR) (version 2.0; Cardiio Inc., USA).
Mobile devices. We tested the four diﬀerent apps on two
diﬀerent portable phones (iPhone 4, iPhone 5). The
exact camera speciﬁcations of the phones are shown
in Table 1. The primary camera was used for the con-
tact PPG-based measurements, while the secondary
camera was used for all non-contact measurements.
Study population
From April to December 2013 we randomly included
adult patients requiring heart rate monitoring on the
chest pain unit or the emergency room of the
University Hospital Zurich, Switzerland. All patients
willing to participate in the study were eligible; how-
ever, patients in critical medical conditions were
excluded from this study. Patients participating in this
Figure 1. Two different concepts of measuring heart rate by PPG are know: In contact PPG, the subject places a finger on the built-in
camera of the phone directly on the skin and the built in flash provides the necessary light source in the visible range for reflection by
blood cells (Figure 1a). In non-contact PPG, the camera is used in the classical way by holding the camera in front of the patients face
without the need for direct skin contact (Figure 1b). (a) Contact photoplethysmography; (b) non-contact photoplethysmography.
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study gave written informed consent. The study was
approved by the ethics committee of the Canton of
Zurich, Switzerland (KEK-ZH-NR: 2012-0524).
After recruitment, initial heart rate and rhythm was
measured using a 12-leadECG (SchillerAT-104PC/SDS
101 and Schiller AT 102 Plus; Schiller AG, Baar,
Switzerland). Heart rate was then measured simultan-
eously by pulse oximetry (Draeger Inﬁnity Delta XL;
Draegerwerk AG & Co. KG, Luebeck, Germany), an
ECG-based monitor (Philips Intellivue X2; Koninklijke
Philips NV, Amsterdam, the Netherlands) and by each
app. The patient historywas taken frommedical records,
and additional clinical characteristics were collected
(age, body temperature, blood pressure and blood
oxygen saturation). The graphic conceived by Jubran13
was used for grading of the pulse oximetry curve quality.
Statistics
Continuous data are expressed as medians and inter-
quartile ranges (IQRs) or as mean standard deviation
(SD) as appropriate, and categorical data as number and
percentage (%). Categorical data were analysed using
the chi-square test. To compare the values provided by
the four apps to the ECG and oximeter-derived heart
rate we used Pearson’s correlation and Bland–Altman
analysis. To assess the level of agreement between meth-
ods we computed the mean absolute error.14 Linear and
multiple regression analyses were performed to test the
inﬂuence of the deﬁned factors on the mean absolute
error of the four diﬀerent apps. A P value of less than
0.05 was considered statistically signiﬁcant. Statistical
analyses were performed using Stata SE, version 13.
Results
Clinical characteristics
We included a total of 108 patients. In total, 432
datasets (each consisting of an app-based
measurement, a simultaneous ECG-based measure-
ment and simultaneous pulseoxymetry-based measure-
ment for each patient) were obtained. Nineteen datasets
were excluded due to missing values (due to either the
app-based measurement or ECG being unable to give a
value). Median patient age was 65 years (range 19–99
years, IQR 52–76 years); 31% of patients were women.
During the measurements, median systolic blood
pressure was 126mmHg (range 76–189mmHg, IQR
112–142mmHg), body temperature ranged from
35.0C to 37.5C (median 36.0C). Median arterial
oxygen saturation measured by pulse oximetry was
96% (range 62–100%, IQR 94–98%). Sinus rhythm
was present in 85 patients (79%), atrial ﬁbrillation in
11 patients (10%), ventricular pacemaker stimulation
in ﬁve patients (5%) and atrial tachycardia/third-
degree AV-block/junctional escape rhythm each in
one patient (1%). The baseline characteristics of the
study population are given in Table 2. In a total of
413 measurements by ECG we recorded a wide heart
rate range from 31 to 124 bpm (median 75 bpm,
IQR 62–90 bpm). The quality of the oximetry
pulse curve was judged to be satisfactory in 86%
Table 1. Camera specifications.
Property
iPhone 4 primary
camera
iPhone 4 secondary
camera
iPhone 5 primary
camera
iPhone 5 secondary
camera
CMOS sensor OV5650 Unknown IMX145-derivative Omnivision
Sensor format 1/3.2’’ (4.54 3.42mm) Unknown 1/3.2’’ (4.54 3.42mm) 1/6’’ (2.6 1.6mm)
Pixel size 1.75 mm Unknown 1.4 mm 1.75 mm
Image capture size 2592 1936 (5MP) 0.3MP 3264 2448 (8MP) 1280 960 (1.2MP)
LED flash Yes No Yes Yes
Focal length 3.85mm Unknown 4.10mm 2.2mm
Aperture F/2.8 Unknown F/2.4 F/2.4
Source: AnandTech.18
Table 2. Baseline characteristics of patients (n¼ 108).
Age 65 (52–76)
Heart rate, beats per minutea 75 (62–90)
Systolic blood pressure (mmHg)a 126 (112–142)
Body temperature (C)a 36 (35.0–37.5)
Arterial oxygen saturation (%)a 96 (94–98)
Female gender, n (%) 35 (31)
Heart rhythm
Sinus rhythm, n (%) 85 (79)
Atrial fibrillation, n (%) 11 (10)
Pacemaker rhythm, n (%) 5 (5)
Other, n (%) 7 (6)
aData given as median (IQR 25–75).
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(IHH measurements), 96% (HF measurements), 80%
(WMH measurements) and 69% (CAR measurements)
of the cases.
ECG measurements compared to pulse oximetry
measurements with approved medical devices
ECG-based measurements compared to heart rate
measurement using the pulse oximetry device showed
a very high level of agreement (Figure 2, Table 3).
Pearson correlation r between the ECG determined
heart rate and the oximetric heart rate was 0.92
(P< 0.001), showing a mean absolute error of
2 0.35 bpm.
ECG measurements compared to app-based
measurements
The accuracy of heart rate measured by apps as com-
pared to ECG, reported as mean absolute error
(in bpm standard error) was 4.5 1.1 (IHR),
2.0 0.5 (HF), 7.1 1.4 (WMH) and 8.1 1.4
(CAR). The ECG-derived heart rate correlated well
with IHR (r¼ 0.83) and HF (r¼ 0.96), but less
with WMH (r¼ 0.62) and CAR (r¼ 0.60) (see
Table 3). The Bland–Altman plots (Figure 3) show
considerable diﬀerences between the tested apps.
Non-contact PPG measurements performed signiﬁ-
cantly worse compared to ﬁngertip-based (contact)
measurements. Both non-contact PPG-based apps
performed signiﬁcantly worse at higher heart rates.
They also have a tendency to underestimate higher
heart rates.
Influencing factors in app-based measurements
Using multiple regression analyses, we were unable to
demonstrate any relationship between inﬂuencing fac-
tors and mean absolute error for the contact PPG apps
IHR and HF (Table 4). However, the two non-contact
PPG apps performed worse, with declining body tem-
perature and increasing heart rate. Furthermore,
camera technology tended to inﬂuence the performance
of the non-contact PPG apps.
Discussion
The widespread use of smartphones, expanding mobile
broadband connectivity and the emergence of new
mHealth technologies will result in an increase of collec-
tion (and transmission) of individualised health-related
data. The potential to increase patient engagement, to
reduce healthcare costs and to improve outcomes is
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Figure 2. Heart rate measurement by electrocardiogram compared to pulse oximetry device.
Table 3. Comparison of heart rate assessed by the four dif-
ferent apps and medically approved pulse oximetry compared to
electrocardiogram.
Measurement method
Mean absolute
error ( SD) Pearson’s r
Instant Heart Rate (IHR) 4.52 (1.12)* 0.83
Heart Fitness (HF) 1.96 (0.48)* 0.96
Whats My Heart Rate (WMH) 7.08 (1.39)* 0.62
Cardiio (CAR) 8.11 (1.38)* 0.61
Pulse oximetry 2.0 (0.35)* 0.92
*P< 0.001.
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remarkable. Nevertheless, establishing reliable and clin-
ically meaningful digital health data is problematic: in
the present study, the performance of diﬀerent apps for
heart rate measurements by smartphone (without any
external connectable sensor device) was very heteroge-
neous. While one app (HF) measured heart rate with
comparable accuracy to pulse oximetry, other apps did
not perform as well. In some apps, absolute diﬀerences
of over 20 bpm (or even more) occurred in more than
20% of all measurements (see Table 5). The precise
reason for WMH and CAR performing slightly worse
is unclear. Theoretically they should be performing simi-
larly. We could not reliably identify an inﬂuencing
factor. The two non-contact PPG apps performed sig-
niﬁcantly worse compared to ﬁngertip-based (contact
PPG) apps. This may be to due to inferior camera tech-
nology (in both apps the front camera with less
advanced speciﬁcations was used) as well as generally
a more demanding measurement environment.
Uncontrolled ambient light may make it more diﬃcult
to discriminate between two distinct peaks in the pulse
wave. Furthermore, the accuracy of non-contact PPG
apps was signiﬁcantly worse at higher heart rates,
which is in line with previously published data.15,16 In
a diﬀerent more recent study comparing the accuracy of
wrist-worn heart rate monitors using contact PPG tech-
nology, no such eﬀect was observed.16 One possible
explanation for the worse accuracy of non-contact
PPG could be the inferior resolution of the secondary
camera. The trend to more reliable performance in next
generation devices (iPhone5 vs. iPhone4) observed in the
present study could prognosticate better performance in
the future using more advanced camera technology.
While some apps are developed using evidence-based
guidelines and are continuously evaluated,17 most
remain unevaluated. The sheer number of unregulated
apps can lead to consumer confusion, reluctant promo-
tion by healthcare providers and unnecessary
80
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Figure 3. The Bland-Altman plots show considerable differences between the tested apps. Non-contact PPG measurements per-
formed significantly worse compared to contact measurements. Both non-contact PPG based apps performed significantly worse at
higher heart rates. They also have a tendency to underestimate higher heart rates. (a) Contact photoplethysmography; (b) non-contact
photoplethysmography.
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consumption of healthcare resources. It is largely unclear
how we should develop the resources necessary for
administrating digital health services and the require-
ment for healthcare personnel to monitor the wave of
incoming patient-generated data. Besides these logistic
aspects, several other issues are problematic and need to
be addressed (medico-legal liability, personal data
safety, health insurance collaborations, reimbursement,
incorporation in governmental healthcare systems/pro-
grammes, etc.).
Nevertheless, mHealth technologies potentially oﬀer
amazing opportunities for patients, healthcare pro-
viders, researchers and healthcare delivery systems.
To identify the most eﬀective and robust technologies
for clinical use it is mandatory to create an evidence
base that validates generated measurements and
assesses the impact of speciﬁc mHealth products and
concepts on healthcare quality, cost and outcomes.
Conclusion
We found substantial performance diﬀerences between
the four studied heart rate measuring apps. The two
contact PPG-based apps had higher feasibility and
better accuracy for heart rate measurement than the
two non-contact PPG-based apps. Careful analysis of
app accuracy is warranted before using these apps in
clinical practice.
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Table 4. Influencing factors in App-based measurements.
Simple regression Multiple regression
Value P value Value P value
Instant Heart Rate (IHR)
Age 0.0580* (0.0390) 0.0482 (0.145)
Temperature 0.0584* (0.0206) 0.00956 (0.896)
iPhone 5 2.778 (0.153) 3.497 (0.132)
Heart rate 0.000704 (0.989) 0.0298 (0.651)
Atrial fibrillation 0.334 (0.860) 1.592 (0.576)
Male gender 3.161 (0.105) 3.909 (0.0909)
Systolic blood
pressure
0.0914 (0.123) 0.101 (0.141)
Heart Fitness (HF)
Age 0.00354 (0.770) 0.00573 (0.606)
Temperature 0.0108 (0.204) 0.15 (0.0852)
iPhone 5 0.441 (0.638) 0.215 (0.764)
Heart rate 0.0320 (0.319) 0.0223 (0.521)
Atrial fibrillation 5.312 (0.129) 7.322 (0.0680)
Male gender 0.701 (0.561) 0.624 (0.580)
Systolic blood
pressure
0.0181 (0.469) 0.000145 (0.991)
Whats My Heart Rate (WMH)
Age 0.0473 (0.611) 0.00385 (0.953)
Temperature 0.0774 (0.0669) 0.359* (0.00153)
iPhone 5 6.892* (0.00249) 4.198* (0.0329)
Heart rate 0.406* (0.000135) 0.390* (0.000168)
Atrial fibrillation 2.223 (0.719) 2.041 (0.645)
Male gender 0.939 (0.768) 0.950 (0.711)
Systolic blood
pressure
0.105 (0.123) 0.0614 (0.282)
Cardiio (CAR)
Age 0.0671 (0.382) 0.0447 (0.510)
Temperature 0.119* (0.000167) 0.374* (0.00104)
iPhone 5 6.044* (0.0162) 4.394 (0.0642)
Heart rate 0.336* (0.00205) 0.294* (0.0147)
Atrial fibrillation 0.989 (0.781) 2.081 (0.643)
Male gender 2.074 (0.505) 0.352 (0.895)
Systolic blood
pressure
0.168* (0.0226) 0.0937 (0.115)
*P< 0.05.
Table 5. App-performance grouped by differences (bpm) to
ECG.
Instant Heart
Rate (IHR)
Heart
Fitness
(HF)
Whats
My Heart
Rate (WMH)
Cardiio
(CAR)
Difference
to ECG
(bpm)
Percentage of
measurements
>10 13 6 19 20
>20 7 4 14 15
>40 2 3 9 5
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